JFL Life Sciences Limited (NSE:JFLLIFE)
9.45
0.00 (0.00%)
At close: Jun 15, 2026
JFL Life Sciences Revenue
In the fiscal year ending March 31, 2026, JFL Life Sciences had annual revenue of 1.31B INR with 60.22% growth. JFL Life Sciences had revenue of 630.54M in the quarter ending March 31, 2026, with 282.31% growth.
Revenue
1.31B
Revenue Growth
+60.22%
P/S Ratio
0.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
311.81M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.31B | 494.09M | 60.22% |
| Mar 31, 2025 | 820.42M | 350.23M | 74.49% |
| Mar 31, 2024 | 470.19M | 28.09M | 6.35% |
| Mar 31, 2023 | 442.10M | 99.00M | 28.85% |
| Mar 31, 2022 | 343.10M | 15.40M | 4.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| ANG Lifesciences India | 862.13M |
| Deccan Health Care | 819.05M |
| Walpar Nutritions | 757.46M |
| Sandu Pharmaceuticals | 699.35M |
| Panjon | 476.21M |
| Gujarat Terce Laboratories | 474.73M |